Top

Arthritis Research & Therapy

Published in:

01-09-2003 | Article selection

Articles selected from Faculty of 1000 in July 2003

Author: Iain McInnes

Published in: Arthritis Research & Therapy | Issue 4/2003

Excerpt

Articles selected from Faculty of 1000 …

Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, Baldwin AS: A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature. 2003, 423 (6940): 659-663. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar798.asp#AnestCrossRefPubMed

Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A: IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol. 2003, 4 (6): 551-556. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar798.asp#YasukawaCrossRefPubMed

Mottet C, Uhlig HH, Powrie F: Cutting Edge: Cure of Colitis by CD4(+)CD25(+) Regulatory T Cells. J Immunol. 2003, 170 (8): 3939-3943. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar798.asp#MottetCrossRefPubMed

Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, Kastner DL: Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003, 11 (3): 591-604. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar798.asp#ChaeCrossRefPubMed

Reinhardt RL, Bullard DC, Weaver CT, Jenkins MK: Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med. 2003, 197 (6): 751-762. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar798.asp#ReinhardtPubMedCentralCrossRefPubMed

Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H: Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat Med. 2003, 9 (3): 287-293. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar798.asp#YanCrossRefPubMed

Title: Articles selected from Faculty of 1000 in July 2003
Author: Iain McInnes
Publication date: 01-09-2003
Publisher: BioMed Central
Published in: Arthritis Research & Therapy / Issue 4/2003
Electronic ISSN: 1478-6362
DOI: https://doi.org/10.1186/ar798

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2003

SLE - Rituximab in lupus

Put your heart into the joint benefits of statins!

The use and abuse of commercial kits used to detect autoantibodies

DEK binding to class II MHC Y-box sequences is gene- and allele-specific

Cytokines in systemic lupus erythematosus, London, UK

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials